title: Should routine serological screening for HCV be mandatory in HIV/AIDS patients enrolling for HAART in South Africa?
authors.affiliation: Department of Virology, University of Limpopo.
authors.forename: Maemu P
authors.initials: MP
authors.lastname: Gededzha
authors.forename: M Jeffrey
authors.initials: MJ
authors.lastname: Mphahlele
authors.forename: Azwidowi
authors.initials: A
authors.lastname: Lukhwareni
authors.forename: Selokela G
authors.initials: SG
authors.lastname: Selabe
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000150:complications / Q000821:virology*; D018937:Hepatitis C Antibodies / Q000032:analysis*; D006801:Humans; D008297:Male; D037141:Mandatory Programs; D008875:Middle Aged; D012189:Retrospective Studies; D012698:Serologic Tests; D013019:South Africa
chemical_list: D018937:Hepatitis C Antibodies